Roles of the melanocortin-4 receptor in antipyretic and hyperthermic actions of centrally administered alpha-MSH.
D018712:Analgesics, Non-Narcotic / Q000008:administration & dosage*; D000818:Animals; D001831:Body Temperature / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D007035:Hypothermia / Q000139:chemically induced / Q000503:physiopathology*; D007276:Injections, Intraventricular / Q000379:methods; D008070:Lipopolysaccharides; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D010456:Peptides, Cyclic / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D044105:Receptor, Melanocortin, Type 4 / Q000037:antagonists & inhibitors / Q000187:drug effects / Q000502:physiology*; D012881:Skin Temperature / Q000187:drug effects; D013997:Time Factors; D000521:alpha-MSH / Q000008:administration & dosage*
D018712:Analgesics, Non-Narcotic; C116941:HS014 cyclic peptide; D008070:Lipopolysaccharides; D010456:Peptides, Cyclic; D044105:Receptor, Melanocortin, Type 4; D000521:alpha-MSH